Report Company Directory
- SOHM, Inc., Targets Revolutionary New ABBIE Genome Editing Kits for Q3, 2024 by GlobeNewsWire
- SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers by GlobeNewsWire
- SOHM Files Provisional Patent on ABBIE’s ‘Smart Gene-Editing’ That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations by GlobeNewsWire
- SOHM Announces Business Outlook for 2024 by GlobeNewsWire
- SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California by GlobeNewsWire
- SOHM OTC Self-care Launches Suite of 13 New SOHM Nutrients’ Brand Chewables by GlobeNewsWire
- SOHM Collaborates with University of Arizona Center for Innovation to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology by GlobeNewsWire
- SOHM Announces Its Acquisition of ABBIE, a World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors by GlobeNewsWire
- SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing as VP of Quality with Immediate Effect by GlobeNewsWire
- SOHM, Inc. Expands Its Advisory Board, Appointing Dr. Krishna Bhat, M.D, Ph.D., FACC, as Chief Medical Advisor by GlobeNewsWire